Stem cells may boost islet transplants for pancreatitis patients
NCT ID NCT05095532
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether adding a person's own bone marrow stem cells to their islet transplant can help the islets survive longer and work better. It includes 42 adults with chronic pancreatitis who are already scheduled for pancreas removal and islet auto-transplant. Participants are randomly assigned to receive stem cells or standard care, and their blood sugar control is tracked for one year.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC PANCREATITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Medical University of South Carolina
RECRUITINGCharleston, South Carolina, 29425, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Blood and gut clues may flag pancreatic cancer risk early
- Can a lung drug tame the pain of chronic pancreatitis?
- Can a Decades-Old drug reverse pancreatic scarring?
- Can we predict who will develop pancreatic cancer from chronic pancreatitis?
- Brain scans reveal hidden pain pathways in chronic pancreatitis
- New device aims to make pancreatic and bile duct procedures safer